image

© 2025 AiBtl BioPharma.
DISCLAIMER: Clinical trials may be in early stages. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of loss. Past performance is not indicative of future results.

The Future of Biotech & Digital Health

News & Industry Insights

Stay ahead with the latest in biotech, digital health, and AI. Follow us for key industry insights that drive innovation and impact healthcare.

AiBtl BioPharma is committed to advancing its research and development efforts to address critical needs in mental health and central nervous system (CNS) disorders. Our updates reflect scientific progress, clinical milestones, and collaborative efforts with academic and industry partners.

img

Jan 14, 2025

AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees

Read Full News
img

January 18, 2020

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

Read Full News
img

March 21, 2024

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars

Read Full News
image

March 31, 2025

How to apply behavioral science and AI to 11 essential pharma market research projects.

Two of the biggest forces reshaping pharma market research in 2025 are behavioral science and AI. But are you truly leveraging them to their full potential?

Read More

March 28, 2025

Transformative technology trends in biotech for 2026: The Digital and AI Revolution

The biotechnology industry is undergoing a profound digital transformation, with artificial intelligence (AI), cloud computing, and real-time analytics reshaping drug discovery, personalised medicine, and healthcare delivery.

Read More
image